COO Q2 2024 Earnings — The Cooper Companies, Inc. Revenue & Financial Results | Market Cap Arena

COOThe Cooper Companies, Inc.

$15B

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$943M+7.4% YoY

Gross Profit

$631M67.0% margin

Operating Income

$162M17.2% margin

Net Income

$89M9.4% margin

EPS (Diluted)

$0.44

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$111M

Free Cash Flow

$37M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$12.0B

Total Liabilities

$4.2B

Stockholders' Equity

$7.8B

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$943M	$877M	+7.4%
Gross Profit	$631M	$583M	+8.3%
Operating Income	$162M	$96M	+67.9%
Net Income	$89M	$40M	+123.4%

Revenue Segments

Coopervision Segment

$636M67%

Coopersurgical Segment

$307M33%

Geographic Segments

UNITED STATES

$479M51%

Europe

$277M29%

Rest Of World, Excluding United States And Europe

$187M20%